Chief Financial Officer and Chief Business Officer @ Genevant Sciences
Elizabeth Czerepak's Education
Harvard Business School
Corporate Director Certificate (Audit, Compensation and Corporate Governance Committees)
2019 - 2020
NASD (FINRA) Registered Representative
Series 7 and Series 63
2001 - 2008
Rutgers University - Newark
MBA (Finance, Management)
1979 - 1982
Marshall University
B.A. magna cum laude (Secondary Education (Mathematics and Spanish))
1973 - 1976
Elizabeth Czerepak's Skills
Venture Capital
Corporate Development
Biotechnology
Due Diligence
Pharmaceutical Industry
Business Development
Finance
Mergers & Acquisitions
Start-ups
Financial Analysis
Elizabeth Czerepak's Summary
Elizabeth Czerepak, based in New York, NY, US, is currently a CFO, CBO and EVP at Scilex Holding Company, bringing experience from previous roles at Sorrento Therapeutics, Inc., Delcath Systems, Inc and Seed Therapeutics. Elizabeth Czerepak holds a 2019 - 2020 Corporate Director Certificate in Audit, Compensation and Corporate Governance Committees @ Harvard Business School. With a robust skill set that includes Venture Capital, Corporate Development, Biotechnology, Due Diligence, Pharmaceutical Industry and more, Elizabeth Czerepak contributes valuable insights to the industry. Elizabeth Czerepak has 9 emails and 1 mobile phone number on RocketReach.